BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 8, 2004
View Archived Issues
A sustained-release formulation of lanreotide shows efficacy in acromegaly
Read More
Good safety and pharmacokinetic profile of intranasal PYY3-36 in healthy volunteers
Read More
Oralin reported to improve mealtime glycemic control in type 2 diabetes
Read More
Comparison of sleep induction with melatonin, zaleplon, zopiclone and temazepam
Read More
Elan submits Prialt NDA amendment
Read More
Remoxy results demonstrate Oradur utility
Read More
ZymoGenetics licenses to Novo Nordisk rights to IL-28A, IL-29 and IL-31
Read More
FDA approval of NeutroSpec for diagnosis of appendicitis
Read More
ViraGen licenses Oxford BioMedica's LentiVector gene delivery technology
Read More
AltaRex signs distribution agreement with Dompe
Read More
sBLA filed for Bexxar
Read More
NeoRx files IND for phase II study of STR in metastatic breast cancer
Read More
IDEA receives milestone for progression of targeted pain therapeutic
Read More
Second clinical trial evaluates trans-NV-04
Read More
Pharming and Esteve reach agreement on rhC1INH
Read More
NexMed and Schering AG sign Alprox-TD agreement
Read More
U.S. phase II study of FM-VP4 planned for next year
Read More
Pharmion launches Vidaza
Read More
Forest and PAION enter agreement for desmoteplase in U.S. and Canada
Read More
Guidant and Miravant to collaborate on cardiovascular PDT development
Read More
Dosing commences in phase III trial of TransMID for glioblastoma multiforme
Read More
Positive opinion handed down in Europe for Protelos
Read More
Wilzin recommended for approval in Europe for Wilson's disease
Read More
Novel DPP-IV inhibitors claimed by Boehringer Ingelheim
Read More
FKBP12 ligands for neurodegenerative diseases in early development at Taisho
Read More
Boehringer Ingelheim patent describes series of cytokine inhibitors
Read More
Modulators of tyrosine kinase-mediated signal transduction disclosed in patent
Read More
PDE4 inhibitors prepared and tested at elbion
Read More
Gastric and intestinal protectants claimed in Altana patent
Read More